You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 147 No. 1, January 1987 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (32)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

B-Cell Activation and Immunoregulation in End-Stage Renal Disease Patients Receiving Hemodialysis

Jana Raskova, MD; Ibrahim Ghobrial, MSc; Debra K. Czerwinski; Stephen M. Shea, MD; Robert P. Eisinger, MD; Karel Raska, Jr, MD, PhD

Arch Intern Med. 1987;147(1):89-93.


Abstract



• B-lymphocyte functions were studied in peripheral blood mononuclear cells of end-stage renal disease patients undergoing intermittent hemodialysis for longer than two years. T-cell—dependent B lymphocyte proliferation after pokeweed mitogen stimulation was low in half of the hemodialyzed patients. T cell—independent B cell response to Staphylococcus aureus, Cowan I, was also significantly reduced. Spontaneous production of immunoglobulin in cultures of peripheral blood mononuclear cells of uremic patients was comparable with that of healthy controls, but pokeweed mitogen—stimulated antibody secretion was significantly reduced with cells from patients undergoing hemodialysis. Helper T-cell functions in B-cell activation were also qualitatively deficient in uremic patients. It is concluded that B-cell activation and immunoregulation is defective in patients undergoing long-term hemodialysis.

(Arch Intern Med 1987;147:89-93)



Author Affiliations



From the Departments of Pathology (Drs Raskova, Shea, and Raska and Mr Ghobrial and Ms Czerwinski) and Medicine (Dr Eisinger), University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, Piscataway; and Middlesex General-University Hospital (Drs Raskova, Shea, Eisinger, and Raska), New Brunswick, NJ.


Footnotes



Accepted for publication April 23, 1986.

Reprint requests to Department of Pathology, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, Piscataway, NJ 08854 (Dr Raska).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Potential role of the soluble form of CD40 in deficient immunological function of dialysis patients: new findings of its amelioration using polymethylmethacrylate (PMMA) membrane
Contin-Bordes et al.
Clin Kidney J 2010;3:i20-i27.
ABSTRACT | FULL TEXT  

Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression
Pahl et al.
Nephrol Dial Transplant 2010;25:205-212.
ABSTRACT | FULL TEXT  

B lymphopenia in uraemia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2
Fernandez-Fresnedo et al.
Nephrol Dial Transplant 2000;15:502-510.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.